Literature DB >> 18311837

Late onset Wilson's disease: therapeutic implications.

Anna Członkowska1, Maria Rodo, Grazyna Gromadzka.   

Abstract

The clinical symptoms of Wilson's disease (WD) usually develop between 3 and 40 years of age and include signs of liver and/or neurologic and psychiatric disease. We report on an 84-year-old woman with WD. Despite the absence of treatment, the only symptom she presented with, until the age of 74 years, was Kayser-Fleisher rings. At the age of 74, she developed slightly abnormal liver function. This case raises the following issues: (a) Should WD be considered in all patients of all ages who manifest signs related to the disease? (b) Are ATP7B mutations fully penetrant? (c) Should all patients diagnosed presymptomatically receive anticopper therapy? (c) 2008 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18311837     DOI: 10.1002/mds.21985

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  14 in total

Review 1.  Update on the Diagnosis and Management of Wilson Disease.

Authors:  Eve A Roberts
Journal:  Curr Gastroenterol Rep       Date:  2018-11-05

2.  Difficulties in diagnosis and treatment of Wilson disease-a case series of five patients.

Authors:  Anna Członkowska; Karolina Dzieżyc-Jaworska; Bożena Kłysz; Rędzia-Ogrodnik Barbara; Tomasz Litwin
Journal:  Ann Transl Med       Date:  2019-04

3.  Structural and neurochemical evaluation of the brain and pons in patients with Wilson's disease.

Authors:  Oktay Algin; Ozlem Taskapilioglu; Bahattin Hakyemez; Gokhan Ocakoglu; Sukran Yurtogullari; Sevda Erer; Mufit Parlak
Journal:  Jpn J Radiol       Date:  2010-11-27       Impact factor: 2.374

Review 4.  Late onset fulminant Wilson's disease: a case report and review of the literature.

Authors:  Ella Weitzman; Orit Pappo; Peretz Weiss; Moshe Frydman; Yael Haviv-Yadid; Ziv Ben Ari
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

Review 5.  Assessment of patients with isolated or combined dystonia: an update on dystonia syndromes.

Authors:  Victor S C Fung; H A Jinnah; Kailash Bhatia; Marie Vidailhet
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

Review 6.  Genetics of Wilson's disease: a clinical perspective.

Authors:  S Suresh Kumar; George Kurian; C E Eapen; Eve A Roberts
Journal:  Indian J Gastroenterol       Date:  2012-09-01

7.  A genetic study of Wilson's disease in the United Kingdom.

Authors:  Alison J Coffey; Miranda Durkie; Stephen Hague; Kirsten McLay; Jennifer Emmerson; Christine Lo; Stefanie Klaffke; Christopher J Joyce; Anil Dhawan; Nedim Hadzic; Giorgina Mieli-Vergani; Richard Kirk; K Elizabeth Allen; David Nicholl; Siew Wong; William Griffiths; Sarah Smithson; Nicola Giffin; Ali Taha; Sally Connolly; Godfrey T Gillett; Stuart Tanner; Jim Bonham; Basil Sharrack; Aarno Palotie; Magnus Rattray; Ann Dalton; Oliver Bandmann
Journal:  Brain       Date:  2013-03-21       Impact factor: 13.501

8.  Wilson's disease in an adult asymptomatic patient: a potential role for modifying factors of copper metabolism.

Authors:  Georgios Loudianos; Simona Incollu; Eva Mameli; Maria B Lepori
Journal:  Ann Gastroenterol       Date:  2016 Jan-Mar

9.  Three novel mutations in the ATP7B gene of unrelated Vietnamese patients with Wilson disease.

Authors:  Nguyen Thi Mai Huong; Nguyen Thi Kim Lien; Ngo Diem Ngoc; Nguyen Thi Phuong Mai; Nguyen Pham Anh Hoa; Le Thanh Hai; Phan Van Chi; Ta Thanh Van; Tran Van Khanh; Nguyen Huy Hoang
Journal:  BMC Med Genet       Date:  2018-06-18       Impact factor: 2.103

10.  Curcumin Effect on Copper Transport in HepG2 Cells.

Authors:  Anita Berzina; Inese Martinsone; Simons Svirskis; Modra Murovska; Martins Kalis
Journal:  Medicina (Kaunas)       Date:  2018-04-12       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.